Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

WEST PHARMACEUTICAL SERVICES INC Director's Dealing 2007

Aug 10, 2007

30339_dirs_2007-08-10_1b079527-0aec-4744-9ad5-3c99722ddf78.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC ((WST))
CIK: 0000105770
Period of Report: 2007-08-09

Reporting Person: YOUNG ROBERT C (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2007-08-09 Common Stock M 1932 $19.3650 Acquired 11032.0000 Direct
2007-08-09 Common Stock F 932 $40.1500 Disposed 10100.0000 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2007-08-09 Stock Option (Right to Buy) $19.3650 M 1932 Disposed 2015-05-05 Common Stock (1932.0000) Direct

Footnotes

F1: Purchased option shares through a net exercise by directing the Company to retain as payment from the total exercise cost sufficient shares of Common Stock that would otherwise have been received upon this exercise and received the net balance in option shares.